{"gene":"SP3","run_date":"2026-06-10T07:46:38","timeline":{"discoveries":[{"year":1994,"finding":"Sp3 represses Sp1-mediated transcriptional activation by competing with Sp1 for shared GC-box DNA binding sites; an Sp3 mutant lacking the DNA-binding domain does not repress Sp1, indicating competition for binding sites is the mechanism. Chimeric protein experiments showed neither the glutamine-rich domains A/B nor domain D of Sp1 can be replaced by homologous Sp3 regions to restore activation.","method":"Co-transfection in mammalian cells and Drosophila SL2 cells; chimeric protein constructs; antibody characterization","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (co-transfection, DBD mutant, chimeric proteins), replicated across cell lines","pmids":["8070411"],"is_preprint":false},{"year":1996,"finding":"Sp3 contains a portable repression domain in its amino-terminal region that functions independently of the zinc finger DNA-binding domain; when tethered to a promoter via a heterologous DNA-binding domain or targeted to promoter-proximal RNA, Sp3 represses transcriptional activation by different positive regulators, suggesting repression occurs through protein-protein interaction with components of the general transcription complex.","method":"Fusion protein tethering to promoter DNA; RNA tethering assay; co-transfection in mammalian cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — two orthogonal tethering strategies, single lab, direct functional readout","pmids":["8621476"],"is_preprint":false},{"year":1997,"finding":"Sp3 encodes multiple proteins (115 kDa full-length and 80 kDa isoforms) arising from translational initiation at two internal sites within the Sp3 trans-activation domain; the internally initiated isoforms bind GC-box DNA but lack transcriptional activation capacity and instead function as potent inhibitors of Sp1/Sp3-mediated transcription.","method":"Identification of internal translation initiation sites; in vitro binding assays; co-transfection in mammalian and SL2 cells","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct demonstration of internal initiation, DNA binding assay, functional co-transfection, single lab","pmids":["9224612"],"is_preprint":false},{"year":2001,"finding":"Sp3 transcriptional activity is regulated by acetylation; a single lysine residue is responsible for low transcriptional activity of Sp3 in vivo, and Sp3 (but not a lysine-deficient mutant) is highly acetylated in vivo. In an in vitro transcription assay using Sp1/Sp3-depleted HeLa nuclear extract, recombinant Sp3 acts as a strong activator comparable to Sp1.","method":"In vitro transcription assay; mutational analysis; in vivo acetylation detection; stable transfection of insect cells for recombinant protein","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro transcription assay plus mutagenesis plus in vivo acetylation, single lab but multiple orthogonal methods","pmids":["11812829"],"is_preprint":false},{"year":2002,"finding":"Sp3 is SUMOylated in vivo and in vitro at a single lysine within the sequence IKXE located between the second glutamine-rich activation domain and the DNA-binding domain; PIAS1 acts as an E3 SUMO ligase for Sp3 by interacting with both Sp3 and Ubc9 and strongly stimulating SUMO conjugation to Sp3. All mutations that prevented SUMOylation strongly enhanced Sp3 transcriptional activity, demonstrating that SUMO modification silences Sp3. DNA-bound Sp3 does not act as a substrate for SUMO modification.","method":"In vivo and in vitro SUMO conjugation assays; mutational analysis; co-immunoprecipitation identifying PIAS1 as E3 ligase; co-transfection transcription assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution, mutagenesis, E3 identification, functional transcription readout, multiple orthogonal methods","pmids":["12356736"],"is_preprint":false},{"year":2002,"finding":"Sp1 and Sp3 form separate complexes in estrogen-dependent breast cancer cells; both complexes associate with histone deacetylases (HDACs) 1 and 2. The HDAC2 bound to Sp1 and Sp3 complexes is highly enriched in a CK2-phosphorylated form, and protein kinase CK2 is associated with and phosphorylates HDAC2. Alkaline phosphatase treatment reduces HDAC activity in these complexes.","method":"Co-immunoprecipitation; in situ cross-linking; CK2 kinase assay; alkaline phosphatase treatment","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP, in vitro kinase assay, phosphatase treatment, single lab with multiple methods","pmids":["12176973"],"is_preprint":false},{"year":2003,"finding":"Acetylated Sp3 functions as a transcriptional activator; histone acetyltransferase p300 acetylates Sp3, and p300-mediated acetylation of Sp3 is required for its activator function. Wild-type p300 but not HAT-domain-deleted p300 stimulates Sp3-mediated promoter activity, demonstrating acetylation as a switch controlling Sp3 repressor/activator duality.","method":"HAT assay with p300; dominant-negative p300 mutant; co-transfection reporter assays; ectopic Sp3 expression in Sp3-deficient cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct p300 acetylation assay, HAT-mutant control, functional co-transfection, single lab but multiple orthogonal methods","pmids":["12837748"],"is_preprint":false},{"year":2003,"finding":"c-Myc interacts directly with Sp1/Sp3 complexes; the central region of c-Myc interacts with the zinc finger domain of Sp1, and c-Myc co-immunoprecipitates with Sp1/Sp3. This interaction may contribute to Myc-mediated repression of the p21 promoter by sequestering Sp1/Sp3.","method":"Co-immunoprecipitation; GST pulldown assay; co-transfection reporter assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP and GST pulldown, single lab, domain mapping; Sp3 involvement inferred from Sp1/Sp3 complex","pmids":["11274368"],"is_preprint":false},{"year":2003,"finding":"The 116 kDa Sp3 polypeptide binds as a monomer to a single Sp-binding site but forms more stable, slower-migrating complexes at adjacent Sp-binding sites. These multimeric Sp3-DNA complexes are significantly more stable than monomeric Sp3-DNA or multimeric Sp1-DNA complexes, allowing Sp3 to compete with Sp1 for promoters containing multiple Sp sites and thereby block Sp1 synergistic transactivation.","method":"Electrophoretic mobility shift assay (EMSA); competition binding assays; co-transfection reporter assays","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — EMSA-based binding analysis plus functional reporter, single lab, two complementary methods","pmids":["12954773"],"is_preprint":false},{"year":2005,"finding":"Sp1 and Sp3 are organized into distinct, non-overlapping nuclear domains in human breast and ovarian cells; Sp3 partitions with the tightly bound nuclear protein fraction whereas only a subpopulation of Sp1 does so. Both are bound to the nuclear matrix at different sites. Re-ChIP assays show that although Sp1 and Sp3 both bind the trefoil factor 1 (TFF1) promoter, they do not occupy the same promoter molecule simultaneously.","method":"Indirect immunofluorescence microscopy with deconvolution; nuclear fractionation; chromatin immunoprecipitation (ChIP) and re-ChIP","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct localization by imaging, nuclear fractionation, and re-ChIP, single lab, three orthogonal methods","pmids":["15987735"],"is_preprint":false},{"year":2005,"finding":"Sumoylation of internally initiated Sp3 isoforms (M1 and M2) plays an important role in transcriptional repression; Ubc9 (SUMO-1 conjugating enzyme) was identified as an M2-binding protein by yeast two-hybrid. Mutation of lysine-551 blocks sumoylation of all Sp3 isoforms and converts M1 into a potent transcriptional activator; the repression is insensitive to the HDAC inhibitor trichostatin A.","method":"Yeast two-hybrid screen; Western blot with SUMO-1 antiserum; co-transfection with epitope-tagged SUMO-1; site-directed mutagenesis; reporter assays","journal":"Cellular signalling","confidence":"High","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus in vivo sumoylation plus mutagenesis plus functional reporter, single lab, multiple orthogonal methods","pmids":["15494207"],"is_preprint":false},{"year":2006,"finding":"Sp1 and Sp3 are displaced from condensed chromosomes during mitosis and maintain separate punctate distributions throughout the mitotic process; in metaphase both Sp1 and Sp3 foci show high colocalization with microfilaments (F-actin), suggesting actin involvement in organizing Sp1/Sp3 foci during mitosis. Sp3 re-enters newly formed nuclei prior to Sp1 in late telophase, and both enter before RNA polymerase II.","method":"Indirect immunofluorescence microscopy; image deconvolution; Western blot for protein levels during mitosis","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct live-cell and fixed-cell imaging, Western blot, single lab, two complementary methods","pmids":["16492704"],"is_preprint":false},{"year":2008,"finding":"SUMOylation of transcription factors including Sp3, when bound to DNA, provokes establishment of compacted repressive chromatin with heterochromatic characteristics; SUMO-dependent recruitment of chromatin remodeler Mi-2, MBT-domain proteins, heterochromatic protein 1 (HP1), and histone methyltransferases SETDB1 and SUV4-20H is induced, concomitant with H3K9 and H4K20 trimethylation.","method":"Chromatin immunoprecipitation (ChIP); analysis of histone modifications; functional analysis of SUMO-modified Sp3","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP-based mechanistic dissection with multiple chromatin factors and histone marks, single lab, multiple orthogonal readouts","pmids":["18617891"],"is_preprint":false},{"year":2017,"finding":"Sp3 facilitates recruitment of HDAC2 to synaptic plasticity genes; knockdown of Sp3 phenocopies HDAC2 knockdown by de-repressing synaptic gene expression. An HDAC2 fragment containing the Sp3-binding domain is sufficient to restore synaptic plasticity and memory in a mouse neurodegeneration model.","method":"Integrative genomics; siRNA knockdown; functional screening; viral vector-mediated gene delivery in mouse model","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional genetic epistasis (knockdown phenocopy), domain mapping by fragment rescue in vivo, single lab","pmids":["28793257"],"is_preprint":false},{"year":2000,"finding":"Sp3 is required for late tooth development and post-natal survival; Sp3-null mice die at birth of respiratory failure and display pronounced defects in ameloblast-specific gene expression and dentin/enamel formation. Comparison with Sp1 knockout demonstrates distinct in vivo functions with partial redundancy.","method":"Homologous recombination (gene knockout in mice); histological analysis; gene expression analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic knockout with defined cellular/molecular phenotype, multiple organ phenotypes characterized","pmids":["10675334"],"is_preprint":false},{"year":2001,"finding":"Sp3 is required for proper skeletal ossification; both endochondral and intramembranous ossification are impaired in Sp3-null embryos. Reduced osteocalcin expression reflects impaired osteoblast function. Cbfa1 expression is normal in Sp3-null mice, placing Sp3 downstream of or parallel to Cbfa1 in the bone formation pathway. Sp3-null ES cells show reduced capacity for osteogenic differentiation in vitro.","method":"Sp3 knockout mouse analysis; in vitro ES cell osteogenic differentiation; gene expression analysis; histology","journal":"Mechanisms of development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with defined molecular phenotype, in vitro differentiation validation, epistasis with Cbfa1","pmids":["11472836"],"is_preprint":false},{"year":2003,"finding":"Sp3 is required for normal erythroid and myeloid hematopoiesis in a cell-autonomous manner; Sp3-null fetal liver cells fail to engraft the erythroid and myeloid lineages in transplantation assays. Sp3-null mice also show partial arrest of T-cell development and reduced B-cell numbers.","method":"Sp3 knockout mouse analysis; in vivo bone marrow transplantation assay; in vitro differentiation assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with cell-autonomous transplantation assay, multiple hematopoietic lineages analyzed","pmids":["12676787"],"is_preprint":false},{"year":2007,"finding":"Sp3 is required for normal cardiac development; Sp3-null hearts display defective looping at E10.5 and severe cardiac malformations at E14.5. Sp3 directly binds the Carp (cardiac ankyrin repeat protein) promoter in vivo and regulates its expression; Wt1 expression in epicardium-derived cells is diminished in Sp3-null hearts.","method":"Sp3 knockout mouse analysis (C57BL/6 background); chromatin immunoprecipitation (ChIP); microarray analysis; expression pattern analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic KO with defined phenotype, direct ChIP evidence for Carp as Sp3 target, microarray","pmids":["17923686"],"is_preprint":false},{"year":2014,"finding":"Simultaneous loss of both Sp1 and Sp3 (but not either alone) in megakaryocytes causes severe macrothrombocytopenia in a cell-autonomous manner; double-knockout megakaryocytes display a less compact demarcation membrane system and striking inability to form proplatelets. Sp1/Sp3 depletion downregulates cytoskeleton-related proteins and MYLK kinase, providing a mechanistic link to proplatelet defects.","method":"Conditional double-knockout mice (Mx1-Cre and Pf4-Cre); flow cytometry; electron microscopy; megakaryocyte transcriptomics; platelet proteomics","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional double-KO with mechanistic molecular phenotype identified by transcriptomics/proteomics, replicated in two Cre models","pmids":["25538045"],"is_preprint":false},{"year":2003,"finding":"Sp1 and Sp3 are induced by oxidative stress in cortical neurons; sustained high-level expression of full-length Sp1 or full-length Sp3 (but not the Sp1 zinc finger domain alone) prevents neuronal death in response to oxidative stress, DNA damage, or both, establishing them as antideath transcription factors in neurons.","method":"Oxidative stress induction; Western blot; HSV vector-mediated overexpression; survival assays in cortical neurons and in vivo rodent models","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct overexpression with survival readout, domain requirement established, single lab","pmids":["12736330"],"is_preprint":false},{"year":2015,"finding":"Sp3, together with REST and HDAC1/HDAC2, forms a repressor complex on the ncx1 brain promoter during ischemia, leading to promoter hypoacetylation and reduced NCX1 expression. In contrast, the Sp1/HIF-1/p300 complex activates the same promoter during ischemic preconditioning with concomitant hyperacetylation.","method":"Chromatin immunoprecipitation (ChIP); siRNA knockdown; oxygen-glucose deprivation model; in vivo middle cerebral artery occlusion model; pharmacological HDAC inhibition","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrates complex formation on promoter in vivo, siRNA functional validation, single lab","pmids":["25972164"],"is_preprint":false},{"year":2013,"finding":"NF-κB RELA subunit interacts with SP3 and recruits it to the Fgf-10 promoter during inflammatory signaling; SP3 co-expression reduces SP1-mediated Fgf-10 promoter activity, and increased RELA-SP3 nuclear interactions correlate with reduced FGF-10 expression. The inhibitory function of SP3 requires sequences in the N-terminal region of the protein.","method":"Chromatin immunoprecipitation; co-immunoprecipitation; dominant-negative IκB constructs; constitutively active IKKβ; co-transfection reporter assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus co-IP plus functional reporter with domain mapping, single lab","pmids":["23558680"],"is_preprint":false},{"year":2018,"finding":"p300 acetyltransferase activity and Sp3 acetylation are regulated by sodium butyrate; butyrate increases acetylation of Sp3 (detected by anti-acetyl-lysine antibody in EMSA), and p300 acetyltransferase inhibition by E1A reverses butyrate-induced repression of hIGFBP-3, linking Sp3 acetylation by p300 to transcriptional repression of hIGFBP-3.","method":"EMSA with anti-acetyl-lysine antibody; E1A co-transfection; reporter assays; protein synthesis inhibition","journal":"Journal of pediatric gastroenterology and nutrition","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — EMSA-based detection of acetylated Sp3 plus p300-inhibitor rescue, single lab","pmids":["16456404"],"is_preprint":false},{"year":2002,"finding":"The transcriptional coactivator p300 interacts with Sp3 in vivo and in vitro and activates the Dnmt1 promoter in the presence of Sp3; co-transfection of p300 enhances Sp3-mediated transcription from the Dnmt1 promoter.","method":"Co-immunoprecipitation (in vivo and in vitro); co-transfection reporter assay in Drosophila SL2 cells","journal":"European journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — in vivo and in vitro co-IP plus functional reporter, single lab","pmids":["12071960"],"is_preprint":false},{"year":2001,"finding":"Both Sp1 and Sp3 physically interact with the GABPα subunit through their zinc finger DNA-binding domains; this interaction mediates synergistic activation of the utrophin promoter by Sp1/Sp3 together with GABP.","method":"In vitro pull-down (physical interaction); co-transfection in Drosophila SL2 cells; functional domain deletion analysis","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — in vitro pulldown plus domain mapping plus functional synergy in SL2 cells, single lab","pmids":["11237613"],"is_preprint":false},{"year":2016,"finding":"Butyrate activates two different protein kinase C isoforms that differentially phosphorylate Sp1 (dephosphorylation via serine/threonine phosphatases) and Sp3 (phosphorylation via ERK-MAPK); Sp1 dephosphorylation causes its displacement from the TLR5 promoter, while Sp3 phosphorylation promotes its binding and recruitment of p300 with histone acetylation and transcriptional activation.","method":"ChIP; EMSA; PKC isoform inhibitors; ERK-MAPK inhibition; phosphatase treatment; reporter assays; siRNA knockdown","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus pharmacological epistasis plus EMSA, single lab with multiple orthogonal methods","pmids":["27060138"],"is_preprint":false},{"year":2023,"finding":"USP7, activated by ACE inhibitor treatment, translocates to the nucleus and binds Sp1/Sp3; HDAC1 deacetylates Sp1/Sp3. Endothelial Sp1 binds the Notch1 promoter and inhibits its transcription, with Sp3 enhancing this repression; endothelial-specific Sp1/Sp3 double-knockout reduces angiogenesis and activates the Notch1/VEGFR2 pathway.","method":"Endothelial-specific conditional knockout mice; chromatin immunoprecipitation; co-immunoprecipitation; retinal and tumor angiogenesis models","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — cell-type-specific conditional KO with defined pathway epistasis, ChIP evidence for Notch1 promoter binding, co-IP for USP7-Sp1/Sp3 interaction, single lab","pmids":["36759621"],"is_preprint":false},{"year":2005,"finding":"Ceramide reduces Sp3 acetylation and increases the Sp3/Sp1 ratio on the hTERT promoter, enhancing Sp3 repressor function. Ceramide reduces Sp1 binding and increases Sp3 binding to the hTERT promoter, resulting in reduced RNA polymerase II recruitment.","method":"Chromatin immunoprecipitation; EMSA; co-transfection reporter assays; siRNA knockdown of Sp1","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrates in vivo promoter occupancy changes plus acetylation assay, single lab","pmids":["15951564"],"is_preprint":false},{"year":2010,"finding":"Klf4 and Sp3 bind to the Notch1 promoter in keratinocytes and both function as overlapping transcriptional repressors; combined knockdown of Klf4 and Sp3 is required to increase Notch1 transcription, whereas knockdown of either alone is insufficient.","method":"ChIP; siRNA knockdown; reporter assays; overexpression studies","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus siRNA epistasis, single lab, two complementary methods","pmids":["20442780"],"is_preprint":false},{"year":2003,"finding":"Only Sp3 (not Sp1) is a constituent of the interferon-inducible iKIBP complexes at the PKR promoter; Sp3 binding at the KCS element in vivo is IFN-dependent, whereas Sp1 binding is not. Sp3 within the iKIBP complex recruits STAT1 and STAT2 to the KCS element in an IFN-dependent manner, implicating Sp3 specifically in inducible (not basal) PKR transcription.","method":"EMSA; oligonucleotide pull-down; chromatin immunoprecipitation; IFN treatment","journal":"Virology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrates IFN-dependent in vivo binding of Sp3 specifically, pulldown for complex composition, single lab","pmids":["12954221"],"is_preprint":false},{"year":2019,"finding":"Sp1 and Sp3 binding sites largely overlap at chromatin in hematopoietic development; Sp3 cooperates with the Sp1 DNA-binding mutant (Sp1ΔDBD) to enable hematopoiesis but cannot substitute in the complete absence of Sp1. Stable chromatin binding of Sp1 is required to maintain robust differentiation trajectories, as loss of Sp1 DNA binding leads to distortion of cell fate decision timing.","method":"Embryonic stem cell differentiation; single-cell gene expression analysis; chromatin accessibility assays; Sp1 DNA-binding domain mutant cells","journal":"Epigenetics & chromatin","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with defined mutants, single-cell analysis, chromatin profiling, single lab","pmids":["31164147"],"is_preprint":false}],"current_model":"SP3 is a ubiquitously expressed zinc-finger transcription factor that can both activate and repress gene transcription depending on context: it represses Sp1-mediated activation by competing for shared GC-box binding sites and through a portable N-terminal repression domain that contacts the general transcription machinery; its transcriptional activity is regulated by post-translational modifications including acetylation by p300 (which converts it to an activator) and SUMOylation at K551 by the E3 ligase PIAS1 (which silences it by triggering heterochromatic gene silencing via recruitment of Mi-2, HP1, SETDB1, and SUV4-20H); it exists as multiple isoforms (115 kDa full-length plus internally initiated 80 kDa isoforms) with distinct functional properties; it associates with HDAC1/2 complexes (where CK2-phosphorylated HDAC2 is enriched), occupies distinct non-overlapping nuclear domains from Sp1, and is essential in vivo for tooth formation, bone ossification, normal hematopoiesis, cardiac development, and megakaryocyte proplatelet formation."},"narrative":{"mechanistic_narrative":"SP3 is a ubiquitously expressed GC-box-binding zinc-finger transcription factor that acts as a bifunctional regulator, repressing or activating target genes depending on post-translational state and promoter context [PMID:8070411, PMID:12837748]. Its repressor function operates through at least two routes: direct competition with Sp1 for shared GC-box sites — including the formation of unusually stable multimeric SP3-DNA complexes at promoters with adjacent Sp sites that block Sp1 synergy [PMID:8070411, PMID:12954773] — and a portable N-terminal repression domain that acts independently of DNA binding by contacting the general transcription machinery [PMID:8621476]. SP3 also produces internally initiated 80 kDa isoforms that retain GC-box binding but lack activation capacity and act as dominant inhibitors of Sp1/SP3-driven transcription [PMID:9224612]. SP3 activity is set by competing modifications: acetylation by p300 at a single lysine converts SP3 into a strong activator, whereas SUMOylation at K551 — catalyzed by the E3 ligase PIAS1 acting with Ubc9 — silences SP3 and nucleates heterochromatin by recruiting Mi-2, HP1, SETDB1, and SUV4-20H with attendant H3K9/H4K20 trimethylation [PMID:11812829, PMID:12837748, PMID:12356736, PMID:15494207, PMID:18617891]. SP3 partitions into distinct, non-overlapping nuclear domains from Sp1 and associates with HDAC1/2 corepressor complexes to enforce promoter hypoacetylation [PMID:15987735, PMID:12176973, PMID:25972164]. In vivo knockout studies establish non-redundant developmental roles in tooth and enamel formation, skeletal ossification, cardiac morphogenesis, and erythroid/myeloid hematopoiesis, with combined Sp1/SP3 loss required for defects in megakaryocyte proplatelet formation and endothelial angiogenesis [PMID:10675334, PMID:11472836, PMID:12676787, PMID:17923686, PMID:25538045, PMID:36759621].","teleology":[{"year":1994,"claim":"Established the founding mechanism of SP3 as a repressor — whether it antagonizes Sp1 by site competition rather than by a separate effector activity.","evidence":"Co-transfection in mammalian and Drosophila SL2 cells with DNA-binding-domain mutants and Sp1/SP3 chimeras","pmids":["8070411"],"confidence":"High","gaps":["Did not identify protein partners mediating repression beyond competition","Did not address context-dependent activation"]},{"year":1996,"claim":"Showed SP3 carries an autonomous repression activity, not merely passive site occupancy, by demonstrating a portable N-terminal domain that represses when tethered independently of the zinc fingers.","evidence":"DNA and RNA tethering of SP3 fusion proteins in co-transfection assays","pmids":["8621476"],"confidence":"High","gaps":["Specific general-transcription-machinery contacts not biochemically defined"]},{"year":1997,"claim":"Resolved the molecular basis of SP3 functional heterogeneity by demonstrating internally initiated short isoforms that bind DNA but inhibit rather than activate.","evidence":"Internal translation initiation site mapping, in vitro DNA binding, and co-transfection","pmids":["9224612"],"confidence":"High","gaps":["Physiological ratio control of isoforms not established","Isoform-specific gene targets not defined"]},{"year":2000,"claim":"Provided the first in vivo demonstration that SP3 is essential and non-redundant, defining roles in late tooth development and post-natal survival distinct from Sp1.","evidence":"Sp3-null mouse knockout with histology and target gene expression analysis","pmids":["10675334"],"confidence":"High","gaps":["Direct SP3 target genes in ameloblasts not mapped","Degree of Sp1 redundancy quantified only qualitatively"]},{"year":2001,"claim":"Extended SP3's developmental requirement to skeletal ossification and placed it downstream of or parallel to Cbfa1 in bone formation.","evidence":"Sp3-null embryo histology, osteocalcin expression, and in vitro ES cell osteogenic differentiation","pmids":["11472836"],"confidence":"High","gaps":["Direct osteoblast target promoters not identified"]},{"year":2002,"claim":"Identified acetylation as a switch and SUMOylation/PIAS1 as the silencing system, explaining how a single factor toggles between activator and repressor.","evidence":"In vivo/in vitro SUMO conjugation assays, PIAS1/Ubc9 co-IP, single-lysine mutagenesis, and in vitro transcription with depleted nuclear extract","pmids":["12356736","11812829"],"confidence":"High","gaps":["Crosstalk between acetylation and SUMOylation on the same residue context not fully resolved","Stimulus that sets the modification balance not defined here"]},{"year":2002,"claim":"Linked SP3 to HDAC corepressor machinery and showed CK2-phosphorylated HDAC2 is enriched in Sp1/SP3 complexes, connecting kinase signaling to SP3-associated deacetylase activity.","evidence":"Reciprocal co-IP, in situ cross-linking, CK2 kinase and phosphatase assays in breast cancer cells","pmids":["12176973"],"confidence":"High","gaps":["Functional consequence of HDAC2 phosphorylation on specific SP3 targets not shown"]},{"year":2003,"claim":"Demonstrated p300-mediated acetylation is required for SP3 to function as an activator, defining the molecular basis of its repressor/activator duality.","evidence":"p300 HAT assay, HAT-domain-deleted dominant-negative control, and reporter assays in Sp3-deficient cells","pmids":["12837748"],"confidence":"High","gaps":["Promoter features dictating activator versus repressor outcome not generalized"]},{"year":2003,"claim":"Established cell-autonomous requirements for SP3 across hematopoietic lineages, separating its in vivo blood functions from those of Sp1.","evidence":"Sp3-null fetal liver transplantation and in vitro differentiation assays","pmids":["12676787"],"confidence":"High","gaps":["Lineage-specific direct targets not identified"]},{"year":2003,"claim":"Broadened the SP3 interactome to oncogenic and gene-specific contexts — c-Myc sequestration of Sp1/SP3 and IFN-dependent SP3-specific recruitment of STAT1/STAT2 at the PKR promoter.","evidence":"Co-IP and GST pulldown (c-Myc); EMSA, oligo pulldown, and ChIP under IFN treatment (PKR)","pmids":["11274368","12954221"],"confidence":"Medium","gaps":["c-Myc SP3 contact inferred from Sp1/SP3 complex, not direct","Inducible versus basal partitioning mechanism at the KCS element unresolved"]},{"year":2005,"claim":"Showed Sp1 and SP3 occupy spatially and physically distinct nuclear and chromatin compartments, and that SUMOylation of DNA-bound short isoforms (with Ubc9) drives TSA-insensitive repression.","evidence":"Deconvolution immunofluorescence, nuclear fractionation, re-ChIP; yeast two-hybrid and K551 mutagenesis","pmids":["15987735","15494207"],"confidence":"High","gaps":["Mechanism keeping Sp1 and SP3 on separate promoter molecules unknown","Determinants of compartment partitioning not defined"]},{"year":2007,"claim":"Defined a direct developmental SP3 target by showing SP3 binds the Carp promoter and is required for cardiac looping and morphogenesis.","evidence":"Sp3-null mouse phenotyping, ChIP at the Carp promoter, and microarray","pmids":["17923686"],"confidence":"High","gaps":["Whether SP3 acts as activator or repressor at Carp in vivo not fully resolved"]},{"year":2008,"claim":"Provided the chromatin mechanism of SUMO-dependent silencing by showing DNA-bound SUMOylated SP3 nucleates heterochromatin through Mi-2, HP1, SETDB1, and SUV4-20H with H3K9/H4K20 trimethylation.","evidence":"ChIP for chromatin factors and histone marks on SUMO-modified SP3","pmids":["18617891"],"confidence":"High","gaps":["Order and dependency of factor recruitment not dissected","Reversibility kinetics not characterized"]},{"year":2014,"claim":"Revealed functional redundancy with Sp1 in megakaryocytes, where only combined loss disrupts the demarcation membrane system and proplatelet formation via downregulated cytoskeletal genes and MYLK.","evidence":"Conditional Sp1/Sp3 double-knockout mice (two Cre models), EM, transcriptomics, and platelet proteomics","pmids":["25538045"],"confidence":"High","gaps":["Direct SP3 binding at cytoskeletal/MYLK loci not shown","SP3-specific contribution versus Sp1 not separated"]},{"year":2023,"claim":"Connected SP3 to endothelial angiogenesis control, showing SP3 enhances Sp1-mediated Notch1 promoter repression and that USP7 and HDAC1 regulate Sp1/SP3 in this axis.","evidence":"Endothelial-specific Sp1/Sp3 double-knockout mice, ChIP at Notch1, co-IP for USP7 binding, retinal and tumor angiogenesis models","pmids":["36759621"],"confidence":"High","gaps":["Independent SP3 promoter occupancy distinct from Sp1 not isolated","Mechanism of USP7 selectivity for Sp1/SP3 unresolved"]},{"year":null,"claim":"How the acetylation/SUMOylation/phosphorylation code, isoform ratios, and Sp1 redundancy are integrated to select activator versus repressor output at individual native promoters remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking modification state to genome-wide target outcome","SP3-specific direct targets distinct from Sp1 largely undefined","Structural basis of multimeric SP3-DNA complexes unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,2,6]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,2,8]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,2,8]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[9,11]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[9,12]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,6]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[12,5]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[14,15,17]}],"complexes":["HDAC1/2 corepressor complex","REST/HDAC1/HDAC2 repressor complex"],"partners":["SP1","PIAS1","UBE2I","EP300","HDAC2","MYC","RELA","USP7"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q02447","full_name":"Transcription factor Sp3","aliases":["SPR-2"],"length_aa":781,"mass_kda":81.9,"function":"Transcriptional factor that can act as an activator or repressor depending on isoform and/or post-translational modifications. Binds to GT and GC boxes promoter elements. Competes with SP1 for the GC-box promoters. Weak activator of transcription but can activate a number of genes involved in different processes such as cell-cycle regulation, hormone-induction and house-keeping","subcellular_location":"Nucleus; Nucleus, PML body","url":"https://www.uniprot.org/uniprotkb/Q02447/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SP3","classification":"Not Classified","n_dependent_lines":79,"n_total_lines":1208,"dependency_fraction":0.06539735099337748},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SP3","total_profiled":1310},"omim":[{"mim_id":"614353","title":"HAS2 ANTISENSE RNA 1; HAS2AS1","url":"https://www.omim.org/entry/614353"},{"mim_id":"614232","title":"11-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II; HSD11B2","url":"https://www.omim.org/entry/614232"},{"mim_id":"613218","title":"CYTOCHROME b5, TYPE A (MICROSOMAL); CYB5A","url":"https://www.omim.org/entry/613218"},{"mim_id":"609300","title":"CYTOCHROME P450, FAMILY 17, SUBFAMILY A, POLYPEPTIDE 1; CYP17A1","url":"https://www.omim.org/entry/609300"},{"mim_id":"608791","title":"NUCLEOREDOXIN-LIKE PROTEIN 1; NXNL1","url":"https://www.omim.org/entry/608791"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SP3"},"hgnc":{"alias_symbol":["SPR-2"],"prev_symbol":[]},"alphafold":{"accession":"Q02447","domains":[{"cath_id":"3.30.160,3.30.160","chopping":"679-708","consensus_level":"medium","plddt":81.2093,"start":679,"end":708}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q02447","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q02447-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q02447-F1-predicted_aligned_error_v6.png","plddt_mean":37.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SP3","jax_strain_url":"https://www.jax.org/strain/search?query=SP3"},"sequence":{"accession":"Q02447","fasta_url":"https://rest.uniprot.org/uniprotkb/Q02447.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q02447/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q02447"}},"corpus_meta":[{"pmid":"8070411","id":"PMC_8070411","title":"Sp1-mediated transcriptional activation is repressed by Sp3.","date":"1994","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8070411","citation_count":676,"is_preprint":false},{"pmid":"15284899","id":"PMC_15284899","title":"Gene regulation by Sp1 and Sp3.","date":"2004","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/15284899","citation_count":354,"is_preprint":false},{"pmid":"11274368","id":"PMC_11274368","title":"Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11274368","citation_count":352,"is_preprint":false},{"pmid":"20810260","id":"PMC_20810260","title":"The role of Sp1 and Sp3 in normal and cancer cell biology.","date":"2010","source":"Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft","url":"https://pubmed.ncbi.nlm.nih.gov/20810260","citation_count":284,"is_preprint":false},{"pmid":"32129943","id":"PMC_32129943","title":"Automated sample preparation with SP3 for low-input clinical proteomics.","date":"2020","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/32129943","citation_count":232,"is_preprint":false},{"pmid":"9224612","id":"PMC_9224612","title":"Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription.","date":"1997","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/9224612","citation_count":230,"is_preprint":false},{"pmid":"12356736","id":"PMC_12356736","title":"Transcription factor Sp3 is silenced through SUMO modification by PIAS1.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12356736","citation_count":226,"is_preprint":false},{"pmid":"29565595","id":"PMC_29565595","title":"Extending the Compatibility of the SP3 Paramagnetic Bead Processing Approach for Proteomics.","date":"2018","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/29565595","citation_count":217,"is_preprint":false},{"pmid":"12736330","id":"PMC_12736330","title":"Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons.","date":"2003","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12736330","citation_count":195,"is_preprint":false},{"pmid":"10675334","id":"PMC_10675334","title":"Transcription factor Sp3 is essential for post-natal survival and late tooth development.","date":"2000","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10675334","citation_count":170,"is_preprint":false},{"pmid":"11812829","id":"PMC_11812829","title":"Transcription factor Sp3 is regulated by acetylation.","date":"2001","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/11812829","citation_count":129,"is_preprint":false},{"pmid":"8995437","id":"PMC_8995437","title":"Involvement of the Sp3 transcription factor in induction of p21Cip1/WAF1 in keratinocyte differentiation.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8995437","citation_count":129,"is_preprint":false},{"pmid":"11493684","id":"PMC_11493684","title":"Cross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21(WAF1/CIP1) expression in keratinocyte differentiation.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11493684","citation_count":128,"is_preprint":false},{"pmid":"9668119","id":"PMC_9668119","title":"Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9668119","citation_count":122,"is_preprint":false},{"pmid":"12837748","id":"PMC_12837748","title":"Acetylated sp3 is a transcriptional activator.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12837748","citation_count":110,"is_preprint":false},{"pmid":"11472836","id":"PMC_11472836","title":"Impaired ossification in mice lacking the transcription factor Sp3.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11472836","citation_count":98,"is_preprint":false},{"pmid":"9278495","id":"PMC_9278495","title":"Sp3 is a transcriptional activator of the human alpha2(I) collagen gene.","date":"1997","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/9278495","citation_count":91,"is_preprint":false},{"pmid":"12071960","id":"PMC_12071960","title":"Regulation of transcription of the Dnmt1 gene by Sp1 and Sp3 zinc finger proteins.","date":"2002","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12071960","citation_count":89,"is_preprint":false},{"pmid":"25972164","id":"PMC_25972164","title":"Sp3/REST/HDAC1/HDAC2 Complex Represses and Sp1/HIF-1/p300 Complex Activates ncx1 Gene Transcription, in Brain Ischemia and in Ischemic Brain Preconditioning, by Epigenetic Mechanism.","date":"2015","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25972164","citation_count":85,"is_preprint":false},{"pmid":"11390427","id":"PMC_11390427","title":"TNF-alpha downregulates murine hepatic growth hormone receptor expression by inhibiting Sp1 and Sp3 binding.","date":"2001","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/11390427","citation_count":84,"is_preprint":false},{"pmid":"9115370","id":"PMC_9115370","title":"Transcription factor Sp3 antagonizes activation of the ornithine decarboxylase promoter by Sp1.","date":"1997","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/9115370","citation_count":83,"is_preprint":false},{"pmid":"28793257","id":"PMC_28793257","title":"The Transcription Factor Sp3 Cooperates with HDAC2 to Regulate Synaptic Function and Plasticity in Neurons.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28793257","citation_count":83,"is_preprint":false},{"pmid":"12954773","id":"PMC_12954773","title":"Stability of the Sp3-DNA complex is promoter-specific: Sp3 efficiently competes with Sp1 for binding to promoters containing multiple Sp-sites.","date":"2003","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/12954773","citation_count":83,"is_preprint":false},{"pmid":"35848328","id":"PMC_35848328","title":"Solvent Precipitation SP3 (SP4) Enhances Recovery for Proteomics Sample Preparation without Magnetic Beads.","date":"2022","source":"Analytical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35848328","citation_count":82,"is_preprint":false},{"pmid":"26967243","id":"PMC_26967243","title":"Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26967243","citation_count":82,"is_preprint":false},{"pmid":"29901191","id":"PMC_29901191","title":"E2F1/SP3/STAT6 axis is required for IL-4-induced epithelial-mesenchymal transition of colorectal cancer cells.","date":"2018","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29901191","citation_count":81,"is_preprint":false},{"pmid":"11447232","id":"PMC_11447232","title":"Sp3 represses the Sp1-mediated transactivation of the human COL2A1 gene in primary and de-differentiated chondrocytes.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11447232","citation_count":80,"is_preprint":false},{"pmid":"17350596","id":"PMC_17350596","title":"Sp1 and Sp3 regulate basal transcription of the survivin gene.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17350596","citation_count":79,"is_preprint":false},{"pmid":"9325332","id":"PMC_9325332","title":"Sp1 and Sp3 regulate expression of the neuronal nicotinic acetylcholine receptor beta4 subunit gene.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9325332","citation_count":79,"is_preprint":false},{"pmid":"8621476","id":"PMC_8621476","title":"Sp3 represses transcription when tethered to promoter DNA or targeted to promoter proximal RNA.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8621476","citation_count":79,"is_preprint":false},{"pmid":"12176973","id":"PMC_12176973","title":"The transcriptional repressor Sp3 is associated with CK2-phosphorylated histone deacetylase 2.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12176973","citation_count":78,"is_preprint":false},{"pmid":"18522535","id":"PMC_18522535","title":"The human receptor tyrosine kinase Axl gene--promoter characterization and regulation of constitutive expression by Sp1, Sp3 and CpG methylation.","date":"2008","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/18522535","citation_count":78,"is_preprint":false},{"pmid":"18617891","id":"PMC_18617891","title":"SUMO-modified Sp3 represses transcription by provoking local heterochromatic gene silencing.","date":"2008","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/18617891","citation_count":74,"is_preprint":false},{"pmid":"11064455","id":"PMC_11064455","title":"Sp1 and Sp3 activate p21 (WAF1/CIP1) gene transcription in the Caco-2 colon adenocarcinoma cell line.","date":"2000","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11064455","citation_count":72,"is_preprint":false},{"pmid":"33442901","id":"PMC_33442901","title":"SP3-FAIMS Chemoproteomics for High-Coverage Profiling of the Human Cysteinome*.","date":"2021","source":"Chembiochem : a European journal of chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/33442901","citation_count":67,"is_preprint":false},{"pmid":"11237613","id":"PMC_11237613","title":"Sp1 and Sp3 physically interact and co-operate with GABP for the activation of the utrophin promoter.","date":"2001","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11237613","citation_count":64,"is_preprint":false},{"pmid":"9030545","id":"PMC_9030545","title":"The human POLD1 gene. Identification of an upstream activator sequence, activation by Sp1 and Sp3, and cell cycle regulation.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9030545","citation_count":61,"is_preprint":false},{"pmid":"28844709","id":"PMC_28844709","title":"The miR-491-3p/Sp3/ABCB1 axis attenuates multidrug resistance of hepatocellular carcinoma.","date":"2017","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/28844709","citation_count":57,"is_preprint":false},{"pmid":"15541732","id":"PMC_15541732","title":"Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts.","date":"2005","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/15541732","citation_count":57,"is_preprint":false},{"pmid":"15987735","id":"PMC_15987735","title":"Differential intranuclear organization of transcription factors Sp1 and Sp3.","date":"2005","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/15987735","citation_count":56,"is_preprint":false},{"pmid":"22139845","id":"PMC_22139845","title":"The p65 subunit of NF-κB inhibits COL1A1 gene transcription in human dermal and scleroderma fibroblasts through its recruitment on promoter by protein interaction with transcriptional activators (c-Krox, Sp1, and Sp3).","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22139845","citation_count":56,"is_preprint":false},{"pmid":"26352013","id":"PMC_26352013","title":"Sp1 cooperates with Sp3 to upregulate MALAT1 expression in human hepatocellular carcinoma.","date":"2015","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/26352013","citation_count":54,"is_preprint":false},{"pmid":"17012241","id":"PMC_17012241","title":"Role of cyclooxygenase-2 induction by transcription factor Sp1 and Sp3 in neuronal oxidative and DNA damage response.","date":"2006","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/17012241","citation_count":54,"is_preprint":false},{"pmid":"15816870","id":"PMC_15816870","title":"Sp1 and Sp3 activate transcription of the human dopamine transporter gene.","date":"2005","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15816870","citation_count":52,"is_preprint":false},{"pmid":"25538045","id":"PMC_25538045","title":"Sp1/Sp3 transcription factors regulate hallmarks of megakaryocyte maturation and platelet formation and function.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25538045","citation_count":52,"is_preprint":false},{"pmid":"10556032","id":"PMC_10556032","title":"GLUT1 glucose transporter gene transcription is repressed by Sp3. Evidence for a regulatory role of Sp3 during myogenesis.","date":"1999","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10556032","citation_count":52,"is_preprint":false},{"pmid":"10984499","id":"PMC_10984499","title":"ZIC2 and Sp3 repress Sp1-induced activation of the human D1A dopamine receptor gene.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10984499","citation_count":51,"is_preprint":false},{"pmid":"17343736","id":"PMC_17343736","title":"Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells.","date":"2007","source":"BMC molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17343736","citation_count":51,"is_preprint":false},{"pmid":"12855685","id":"PMC_12855685","title":"Decreased methylation and transcription repressor Sp3 up-regulated human monoamine oxidase (MAO) B expression during Caco-2 differentiation.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12855685","citation_count":48,"is_preprint":false},{"pmid":"35893896","id":"PMC_35893896","title":"Roseburia intestinalis and Its Metabolite Butyrate Inhibit Colitis and Upregulate TLR5 through the SP3 Signaling Pathway.","date":"2022","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/35893896","citation_count":47,"is_preprint":false},{"pmid":"11495920","id":"PMC_11495920","title":"Novel transcriptional regulation of the human CYP3A7 gene by Sp1 and Sp3 through nuclear factor kappa B-like element.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11495920","citation_count":46,"is_preprint":false},{"pmid":"14645238","id":"PMC_14645238","title":"E2F and Sp1/Sp3 Synergize but are not sufficient to activate the MYCN gene in neuroblastomas.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14645238","citation_count":44,"is_preprint":false},{"pmid":"33777071","id":"PMC_33777071","title":"SP3 Protocol for Proteomic Plant Sample Preparation Prior LC-MS/MS.","date":"2021","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/33777071","citation_count":44,"is_preprint":false},{"pmid":"15951564","id":"PMC_15951564","title":"Sp1/Sp3-dependent regulation of human telomerase reverse transcriptase promoter activity by the bioactive sphingolipid ceramide.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15951564","citation_count":43,"is_preprint":false},{"pmid":"11259630","id":"PMC_11259630","title":"Regulation of human monoamine oxidase B gene by Sp1 and Sp3.","date":"2001","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11259630","citation_count":42,"is_preprint":false},{"pmid":"11756440","id":"PMC_11756440","title":"Sp1- and Sp3-mediated transcriptional regulation of the fibroblast growth factor receptor 1 gene in chicken skeletal muscle cells.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11756440","citation_count":42,"is_preprint":false},{"pmid":"16603733","id":"PMC_16603733","title":"Sp1 and Sp3 mediate constitutive transcription of the human hyaluronan synthase 2 gene.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16603733","citation_count":41,"is_preprint":false},{"pmid":"17923686","id":"PMC_17923686","title":"Transcription factor Sp3 knockout mice display serious cardiac malformations.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17923686","citation_count":41,"is_preprint":false},{"pmid":"15451065","id":"PMC_15451065","title":"Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase.","date":"2004","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15451065","citation_count":41,"is_preprint":false},{"pmid":"12676787","id":"PMC_12676787","title":"Impaired hematopoiesis in mice lacking the transcription factor Sp3.","date":"2003","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12676787","citation_count":39,"is_preprint":false},{"pmid":"36759621","id":"PMC_36759621","title":"Angiotensin-converting enzyme inhibitor promotes angiogenesis through Sp1/Sp3-mediated inhibition of notch signaling in male mice.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36759621","citation_count":38,"is_preprint":false},{"pmid":"11054558","id":"PMC_11054558","title":"Sp1 and Sp3 transactivate the RET proto-oncogene promoter.","date":"2000","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/11054558","citation_count":38,"is_preprint":false},{"pmid":"12657578","id":"PMC_12657578","title":"Influence of sp1/sp3 expression on corneal epithelial cells proliferation and differentiation properties in reconstructed tissues.","date":"2003","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/12657578","citation_count":37,"is_preprint":false},{"pmid":"23996530","id":"PMC_23996530","title":"Transcription factors Sp1 and Sp3 regulate expression of human ABCG2 gene and chemoresistance phenotype.","date":"2013","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/23996530","citation_count":36,"is_preprint":false},{"pmid":"16492704","id":"PMC_16492704","title":"Sp1 and Sp3 foci distribution throughout mitosis.","date":"2006","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/16492704","citation_count":36,"is_preprint":false},{"pmid":"20442780","id":"PMC_20442780","title":"Differential control of Notch1 gene transcription by Klf4 and Sp3 transcription factors in normal versus cancer-derived keratinocytes.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20442780","citation_count":36,"is_preprint":false},{"pmid":"23558680","id":"PMC_23558680","title":"Interactions between NF-κB and SP3 connect inflammatory signaling with reduced FGF-10 expression.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23558680","citation_count":35,"is_preprint":false},{"pmid":"15854045","id":"PMC_15854045","title":"Regulation of the expression of peptidylarginine deiminase type II gene (PADI2) in human keratinocytes involves Sp1 and Sp3 transcription factors.","date":"2005","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/15854045","citation_count":35,"is_preprint":false},{"pmid":"10491299","id":"PMC_10491299","title":"The human luteinizing hormone receptor gene promoter: activation by Sp1 and Sp3 and inhibitory regulation.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10491299","citation_count":34,"is_preprint":false},{"pmid":"12954221","id":"PMC_12954221","title":"The PKR kinase promoter binds both Sp1 and Sp3, but only Sp3 functions as part of the interferon-inducible complex with ISGF-3 proteins.","date":"2003","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/12954221","citation_count":33,"is_preprint":false},{"pmid":"16456404","id":"PMC_16456404","title":"Sodium butyrate-mediated Sp3 acetylation represses human insulin-like growth factor binding protein-3 expression in intestinal epithelial cells.","date":"2006","source":"Journal of pediatric gastroenterology and nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/16456404","citation_count":33,"is_preprint":false},{"pmid":"35219905","id":"PMC_35219905","title":"SP3-Enabled Rapid and High Coverage Chemoproteomic Identification of Cell-State-Dependent Redox-Sensitive Cysteines.","date":"2022","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/35219905","citation_count":32,"is_preprint":false},{"pmid":"15849196","id":"PMC_15849196","title":"SP3/SP1 transcription activity regulates specific expression of collagen type X in hypertrophic chondrocytes.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15849196","citation_count":32,"is_preprint":false},{"pmid":"16671893","id":"PMC_16671893","title":"NF-Y and Sp1/Sp3 are involved in the transcriptional regulation of the peptidylarginine deiminase type III gene (PADI3) in human keratinocytes.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16671893","citation_count":32,"is_preprint":false},{"pmid":"18031229","id":"PMC_18031229","title":"Regulation of the dual-function transcription factor Sp3 by SUMO.","date":"2007","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/18031229","citation_count":31,"is_preprint":false},{"pmid":"18314536","id":"PMC_18314536","title":"Transcription factors sp1 and sp3 regulate expression of human extracellular superoxide dismutase in lung fibroblasts.","date":"2008","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18314536","citation_count":31,"is_preprint":false},{"pmid":"11742542","id":"PMC_11742542","title":"Characterization of human cathepsin L promoter and identification of binding sites for NF-Y, Sp1 and Sp3 that are essential for its activity.","date":"2002","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/11742542","citation_count":31,"is_preprint":false},{"pmid":"23028678","id":"PMC_23028678","title":"Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23028678","citation_count":30,"is_preprint":false},{"pmid":"27060138","id":"PMC_27060138","title":"Physiological TLR5 expression in the intestine is regulated by differential DNA binding of Sp1/Sp3 through simultaneous Sp1 dephosphorylation and Sp3 phosphorylation by two different PKC isoforms.","date":"2016","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/27060138","citation_count":30,"is_preprint":false},{"pmid":"11867623","id":"PMC_11867623","title":"Role of Sp1 and Sp3 in the nutrient-regulated expression of the human asparagine synthetase gene.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11867623","citation_count":29,"is_preprint":false},{"pmid":"15494207","id":"PMC_15494207","title":"Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.","date":"2005","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/15494207","citation_count":29,"is_preprint":false},{"pmid":"17517765","id":"PMC_17517765","title":"Sp1 and Sp3 regulate basal transcription of the human APOBEC3G gene.","date":"2007","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/17517765","citation_count":28,"is_preprint":false},{"pmid":"16275928","id":"PMC_16275928","title":"Molecular basis for keratoconus: lack of TrkA expression and its transcriptional repression by Sp3.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16275928","citation_count":28,"is_preprint":false},{"pmid":"15451063","id":"PMC_15451063","title":"Sp3 repression of polymorphic human NRH:quinone oxidoreductase 2 gene promoter.","date":"2004","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15451063","citation_count":28,"is_preprint":false},{"pmid":"17934324","id":"PMC_17934324","title":"Sp3 and sp4 transcription factor levels are increased in brains of patients with Alzheimer's disease.","date":"2007","source":"Neuro-degenerative diseases","url":"https://pubmed.ncbi.nlm.nih.gov/17934324","citation_count":28,"is_preprint":false},{"pmid":"17059557","id":"PMC_17059557","title":"Regulation of neurotrophin-3 gene transcription by Sp3 and Sp4 in neurons.","date":"2006","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17059557","citation_count":26,"is_preprint":false},{"pmid":"31164147","id":"PMC_31164147","title":"Robust hematopoietic specification requires the ubiquitous Sp1 and Sp3 transcription factors.","date":"2019","source":"Epigenetics & chromatin","url":"https://pubmed.ncbi.nlm.nih.gov/31164147","citation_count":26,"is_preprint":false},{"pmid":"19064501","id":"PMC_19064501","title":"Cell confluency-induced Stat3 activation regulates NHE3 expression by recruiting Sp1 and Sp3 to the proximal NHE3 promoter region during epithelial dome formation.","date":"2008","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19064501","citation_count":26,"is_preprint":false},{"pmid":"32721022","id":"PMC_32721022","title":"ZEB1 Mediates Fibrosis in Corneal Endothelial Mesenchymal Transition Through SP1 and SP3.","date":"2020","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/32721022","citation_count":25,"is_preprint":false},{"pmid":"38267487","id":"PMC_38267487","title":"Ratiometric fluorescent sensing of pyrophosphate with sp³-functionalized single-walled carbon nanotubes.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38267487","citation_count":24,"is_preprint":false},{"pmid":"11114295","id":"PMC_11114295","title":"MRG1 expression in fibroblasts is regulated by Sp1/Sp3 and an Ets transcription factor.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11114295","citation_count":23,"is_preprint":false},{"pmid":"19742137","id":"PMC_19742137","title":"Genistein inhibition of topoisomerase IIalpha expression participated by Sp1 and Sp3 in HeLa cell.","date":"2009","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/19742137","citation_count":23,"is_preprint":false},{"pmid":"31626996","id":"PMC_31626996","title":"Multiplexed proteome profiling of carbon source perturbations in two yeast species with SL-SP3-TMT.","date":"2019","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/31626996","citation_count":23,"is_preprint":false},{"pmid":"11890673","id":"PMC_11890673","title":"Sp1 and Sp3 activate the rat connexin40 proximal promoter.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11890673","citation_count":22,"is_preprint":false},{"pmid":"20974858","id":"PMC_20974858","title":"Human glycolipid transfer protein gene (GLTP) expression is regulated by Sp1 and Sp3: involvement of the bioactive sphingolipid ceramide.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20974858","citation_count":22,"is_preprint":false},{"pmid":"14623259","id":"PMC_14623259","title":"AML-1, PU.1, and Sp3 regulate expression of human bactericidal/permeability-increasing protein.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/14623259","citation_count":21,"is_preprint":false},{"pmid":"15708372","id":"PMC_15708372","title":"Sp1 and Sp3 transcription factors upregulate the proximal promoter of the human prostate-specific antigen gene in prostate cancer cells.","date":"2005","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/15708372","citation_count":21,"is_preprint":false},{"pmid":"38056200","id":"PMC_38056200","title":"Menstrual blood-derived stem cells exosomal miR-let-7 to ameliorate pulmonary fibrosis through inhibiting ferroptosis by Sp3/HDAC2/Nrf2 signaling pathway.","date":"2023","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38056200","citation_count":21,"is_preprint":false},{"pmid":"10618488","id":"PMC_10618488","title":"Transcriptional regulation of fatty acid synthase gene and ATP citrate-lyase gene by Sp1 and Sp3 in rat hepatocytes(1).","date":"1999","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10618488","citation_count":21,"is_preprint":false},{"pmid":"18417714","id":"PMC_18417714","title":"Expression patterns of SP1 and SP3 during mouse spermatogenesis: SP1 down-regulation correlates with two successive promoter changes and translationally compromised transcripts.","date":"2008","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/18417714","citation_count":19,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48929,"output_tokens":7887,"usd":0.132546,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17331,"output_tokens":4503,"usd":0.099615,"stage2_stop_reason":"end_turn"},"total_usd":0.232161,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"Sp3 represses Sp1-mediated transcriptional activation by competing with Sp1 for shared GC-box DNA binding sites; an Sp3 mutant lacking the DNA-binding domain does not repress Sp1, indicating competition for binding sites is the mechanism. Chimeric protein experiments showed neither the glutamine-rich domains A/B nor domain D of Sp1 can be replaced by homologous Sp3 regions to restore activation.\",\n      \"method\": \"Co-transfection in mammalian cells and Drosophila SL2 cells; chimeric protein constructs; antibody characterization\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (co-transfection, DBD mutant, chimeric proteins), replicated across cell lines\",\n      \"pmids\": [\"8070411\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Sp3 contains a portable repression domain in its amino-terminal region that functions independently of the zinc finger DNA-binding domain; when tethered to a promoter via a heterologous DNA-binding domain or targeted to promoter-proximal RNA, Sp3 represses transcriptional activation by different positive regulators, suggesting repression occurs through protein-protein interaction with components of the general transcription complex.\",\n      \"method\": \"Fusion protein tethering to promoter DNA; RNA tethering assay; co-transfection in mammalian cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two orthogonal tethering strategies, single lab, direct functional readout\",\n      \"pmids\": [\"8621476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Sp3 encodes multiple proteins (115 kDa full-length and 80 kDa isoforms) arising from translational initiation at two internal sites within the Sp3 trans-activation domain; the internally initiated isoforms bind GC-box DNA but lack transcriptional activation capacity and instead function as potent inhibitors of Sp1/Sp3-mediated transcription.\",\n      \"method\": \"Identification of internal translation initiation sites; in vitro binding assays; co-transfection in mammalian and SL2 cells\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct demonstration of internal initiation, DNA binding assay, functional co-transfection, single lab\",\n      \"pmids\": [\"9224612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Sp3 transcriptional activity is regulated by acetylation; a single lysine residue is responsible for low transcriptional activity of Sp3 in vivo, and Sp3 (but not a lysine-deficient mutant) is highly acetylated in vivo. In an in vitro transcription assay using Sp1/Sp3-depleted HeLa nuclear extract, recombinant Sp3 acts as a strong activator comparable to Sp1.\",\n      \"method\": \"In vitro transcription assay; mutational analysis; in vivo acetylation detection; stable transfection of insect cells for recombinant protein\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro transcription assay plus mutagenesis plus in vivo acetylation, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"11812829\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Sp3 is SUMOylated in vivo and in vitro at a single lysine within the sequence IKXE located between the second glutamine-rich activation domain and the DNA-binding domain; PIAS1 acts as an E3 SUMO ligase for Sp3 by interacting with both Sp3 and Ubc9 and strongly stimulating SUMO conjugation to Sp3. All mutations that prevented SUMOylation strongly enhanced Sp3 transcriptional activity, demonstrating that SUMO modification silences Sp3. DNA-bound Sp3 does not act as a substrate for SUMO modification.\",\n      \"method\": \"In vivo and in vitro SUMO conjugation assays; mutational analysis; co-immunoprecipitation identifying PIAS1 as E3 ligase; co-transfection transcription assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution, mutagenesis, E3 identification, functional transcription readout, multiple orthogonal methods\",\n      \"pmids\": [\"12356736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Sp1 and Sp3 form separate complexes in estrogen-dependent breast cancer cells; both complexes associate with histone deacetylases (HDACs) 1 and 2. The HDAC2 bound to Sp1 and Sp3 complexes is highly enriched in a CK2-phosphorylated form, and protein kinase CK2 is associated with and phosphorylates HDAC2. Alkaline phosphatase treatment reduces HDAC activity in these complexes.\",\n      \"method\": \"Co-immunoprecipitation; in situ cross-linking; CK2 kinase assay; alkaline phosphatase treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP, in vitro kinase assay, phosphatase treatment, single lab with multiple methods\",\n      \"pmids\": [\"12176973\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Acetylated Sp3 functions as a transcriptional activator; histone acetyltransferase p300 acetylates Sp3, and p300-mediated acetylation of Sp3 is required for its activator function. Wild-type p300 but not HAT-domain-deleted p300 stimulates Sp3-mediated promoter activity, demonstrating acetylation as a switch controlling Sp3 repressor/activator duality.\",\n      \"method\": \"HAT assay with p300; dominant-negative p300 mutant; co-transfection reporter assays; ectopic Sp3 expression in Sp3-deficient cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct p300 acetylation assay, HAT-mutant control, functional co-transfection, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"12837748\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"c-Myc interacts directly with Sp1/Sp3 complexes; the central region of c-Myc interacts with the zinc finger domain of Sp1, and c-Myc co-immunoprecipitates with Sp1/Sp3. This interaction may contribute to Myc-mediated repression of the p21 promoter by sequestering Sp1/Sp3.\",\n      \"method\": \"Co-immunoprecipitation; GST pulldown assay; co-transfection reporter assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP and GST pulldown, single lab, domain mapping; Sp3 involvement inferred from Sp1/Sp3 complex\",\n      \"pmids\": [\"11274368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The 116 kDa Sp3 polypeptide binds as a monomer to a single Sp-binding site but forms more stable, slower-migrating complexes at adjacent Sp-binding sites. These multimeric Sp3-DNA complexes are significantly more stable than monomeric Sp3-DNA or multimeric Sp1-DNA complexes, allowing Sp3 to compete with Sp1 for promoters containing multiple Sp sites and thereby block Sp1 synergistic transactivation.\",\n      \"method\": \"Electrophoretic mobility shift assay (EMSA); competition binding assays; co-transfection reporter assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — EMSA-based binding analysis plus functional reporter, single lab, two complementary methods\",\n      \"pmids\": [\"12954773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Sp1 and Sp3 are organized into distinct, non-overlapping nuclear domains in human breast and ovarian cells; Sp3 partitions with the tightly bound nuclear protein fraction whereas only a subpopulation of Sp1 does so. Both are bound to the nuclear matrix at different sites. Re-ChIP assays show that although Sp1 and Sp3 both bind the trefoil factor 1 (TFF1) promoter, they do not occupy the same promoter molecule simultaneously.\",\n      \"method\": \"Indirect immunofluorescence microscopy with deconvolution; nuclear fractionation; chromatin immunoprecipitation (ChIP) and re-ChIP\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization by imaging, nuclear fractionation, and re-ChIP, single lab, three orthogonal methods\",\n      \"pmids\": [\"15987735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Sumoylation of internally initiated Sp3 isoforms (M1 and M2) plays an important role in transcriptional repression; Ubc9 (SUMO-1 conjugating enzyme) was identified as an M2-binding protein by yeast two-hybrid. Mutation of lysine-551 blocks sumoylation of all Sp3 isoforms and converts M1 into a potent transcriptional activator; the repression is insensitive to the HDAC inhibitor trichostatin A.\",\n      \"method\": \"Yeast two-hybrid screen; Western blot with SUMO-1 antiserum; co-transfection with epitope-tagged SUMO-1; site-directed mutagenesis; reporter assays\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus in vivo sumoylation plus mutagenesis plus functional reporter, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"15494207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Sp1 and Sp3 are displaced from condensed chromosomes during mitosis and maintain separate punctate distributions throughout the mitotic process; in metaphase both Sp1 and Sp3 foci show high colocalization with microfilaments (F-actin), suggesting actin involvement in organizing Sp1/Sp3 foci during mitosis. Sp3 re-enters newly formed nuclei prior to Sp1 in late telophase, and both enter before RNA polymerase II.\",\n      \"method\": \"Indirect immunofluorescence microscopy; image deconvolution; Western blot for protein levels during mitosis\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct live-cell and fixed-cell imaging, Western blot, single lab, two complementary methods\",\n      \"pmids\": [\"16492704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"SUMOylation of transcription factors including Sp3, when bound to DNA, provokes establishment of compacted repressive chromatin with heterochromatic characteristics; SUMO-dependent recruitment of chromatin remodeler Mi-2, MBT-domain proteins, heterochromatic protein 1 (HP1), and histone methyltransferases SETDB1 and SUV4-20H is induced, concomitant with H3K9 and H4K20 trimethylation.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP); analysis of histone modifications; functional analysis of SUMO-modified Sp3\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-based mechanistic dissection with multiple chromatin factors and histone marks, single lab, multiple orthogonal readouts\",\n      \"pmids\": [\"18617891\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Sp3 facilitates recruitment of HDAC2 to synaptic plasticity genes; knockdown of Sp3 phenocopies HDAC2 knockdown by de-repressing synaptic gene expression. An HDAC2 fragment containing the Sp3-binding domain is sufficient to restore synaptic plasticity and memory in a mouse neurodegeneration model.\",\n      \"method\": \"Integrative genomics; siRNA knockdown; functional screening; viral vector-mediated gene delivery in mouse model\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional genetic epistasis (knockdown phenocopy), domain mapping by fragment rescue in vivo, single lab\",\n      \"pmids\": [\"28793257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Sp3 is required for late tooth development and post-natal survival; Sp3-null mice die at birth of respiratory failure and display pronounced defects in ameloblast-specific gene expression and dentin/enamel formation. Comparison with Sp1 knockout demonstrates distinct in vivo functions with partial redundancy.\",\n      \"method\": \"Homologous recombination (gene knockout in mice); histological analysis; gene expression analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic knockout with defined cellular/molecular phenotype, multiple organ phenotypes characterized\",\n      \"pmids\": [\"10675334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Sp3 is required for proper skeletal ossification; both endochondral and intramembranous ossification are impaired in Sp3-null embryos. Reduced osteocalcin expression reflects impaired osteoblast function. Cbfa1 expression is normal in Sp3-null mice, placing Sp3 downstream of or parallel to Cbfa1 in the bone formation pathway. Sp3-null ES cells show reduced capacity for osteogenic differentiation in vitro.\",\n      \"method\": \"Sp3 knockout mouse analysis; in vitro ES cell osteogenic differentiation; gene expression analysis; histology\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with defined molecular phenotype, in vitro differentiation validation, epistasis with Cbfa1\",\n      \"pmids\": [\"11472836\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Sp3 is required for normal erythroid and myeloid hematopoiesis in a cell-autonomous manner; Sp3-null fetal liver cells fail to engraft the erythroid and myeloid lineages in transplantation assays. Sp3-null mice also show partial arrest of T-cell development and reduced B-cell numbers.\",\n      \"method\": \"Sp3 knockout mouse analysis; in vivo bone marrow transplantation assay; in vitro differentiation assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with cell-autonomous transplantation assay, multiple hematopoietic lineages analyzed\",\n      \"pmids\": [\"12676787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Sp3 is required for normal cardiac development; Sp3-null hearts display defective looping at E10.5 and severe cardiac malformations at E14.5. Sp3 directly binds the Carp (cardiac ankyrin repeat protein) promoter in vivo and regulates its expression; Wt1 expression in epicardium-derived cells is diminished in Sp3-null hearts.\",\n      \"method\": \"Sp3 knockout mouse analysis (C57BL/6 background); chromatin immunoprecipitation (ChIP); microarray analysis; expression pattern analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with defined phenotype, direct ChIP evidence for Carp as Sp3 target, microarray\",\n      \"pmids\": [\"17923686\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Simultaneous loss of both Sp1 and Sp3 (but not either alone) in megakaryocytes causes severe macrothrombocytopenia in a cell-autonomous manner; double-knockout megakaryocytes display a less compact demarcation membrane system and striking inability to form proplatelets. Sp1/Sp3 depletion downregulates cytoskeleton-related proteins and MYLK kinase, providing a mechanistic link to proplatelet defects.\",\n      \"method\": \"Conditional double-knockout mice (Mx1-Cre and Pf4-Cre); flow cytometry; electron microscopy; megakaryocyte transcriptomics; platelet proteomics\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional double-KO with mechanistic molecular phenotype identified by transcriptomics/proteomics, replicated in two Cre models\",\n      \"pmids\": [\"25538045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Sp1 and Sp3 are induced by oxidative stress in cortical neurons; sustained high-level expression of full-length Sp1 or full-length Sp3 (but not the Sp1 zinc finger domain alone) prevents neuronal death in response to oxidative stress, DNA damage, or both, establishing them as antideath transcription factors in neurons.\",\n      \"method\": \"Oxidative stress induction; Western blot; HSV vector-mediated overexpression; survival assays in cortical neurons and in vivo rodent models\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct overexpression with survival readout, domain requirement established, single lab\",\n      \"pmids\": [\"12736330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Sp3, together with REST and HDAC1/HDAC2, forms a repressor complex on the ncx1 brain promoter during ischemia, leading to promoter hypoacetylation and reduced NCX1 expression. In contrast, the Sp1/HIF-1/p300 complex activates the same promoter during ischemic preconditioning with concomitant hyperacetylation.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP); siRNA knockdown; oxygen-glucose deprivation model; in vivo middle cerebral artery occlusion model; pharmacological HDAC inhibition\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrates complex formation on promoter in vivo, siRNA functional validation, single lab\",\n      \"pmids\": [\"25972164\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NF-κB RELA subunit interacts with SP3 and recruits it to the Fgf-10 promoter during inflammatory signaling; SP3 co-expression reduces SP1-mediated Fgf-10 promoter activity, and increased RELA-SP3 nuclear interactions correlate with reduced FGF-10 expression. The inhibitory function of SP3 requires sequences in the N-terminal region of the protein.\",\n      \"method\": \"Chromatin immunoprecipitation; co-immunoprecipitation; dominant-negative IκB constructs; constitutively active IKKβ; co-transfection reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus co-IP plus functional reporter with domain mapping, single lab\",\n      \"pmids\": [\"23558680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"p300 acetyltransferase activity and Sp3 acetylation are regulated by sodium butyrate; butyrate increases acetylation of Sp3 (detected by anti-acetyl-lysine antibody in EMSA), and p300 acetyltransferase inhibition by E1A reverses butyrate-induced repression of hIGFBP-3, linking Sp3 acetylation by p300 to transcriptional repression of hIGFBP-3.\",\n      \"method\": \"EMSA with anti-acetyl-lysine antibody; E1A co-transfection; reporter assays; protein synthesis inhibition\",\n      \"journal\": \"Journal of pediatric gastroenterology and nutrition\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — EMSA-based detection of acetylated Sp3 plus p300-inhibitor rescue, single lab\",\n      \"pmids\": [\"16456404\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The transcriptional coactivator p300 interacts with Sp3 in vivo and in vitro and activates the Dnmt1 promoter in the presence of Sp3; co-transfection of p300 enhances Sp3-mediated transcription from the Dnmt1 promoter.\",\n      \"method\": \"Co-immunoprecipitation (in vivo and in vitro); co-transfection reporter assay in Drosophila SL2 cells\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — in vivo and in vitro co-IP plus functional reporter, single lab\",\n      \"pmids\": [\"12071960\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Both Sp1 and Sp3 physically interact with the GABPα subunit through their zinc finger DNA-binding domains; this interaction mediates synergistic activation of the utrophin promoter by Sp1/Sp3 together with GABP.\",\n      \"method\": \"In vitro pull-down (physical interaction); co-transfection in Drosophila SL2 cells; functional domain deletion analysis\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — in vitro pulldown plus domain mapping plus functional synergy in SL2 cells, single lab\",\n      \"pmids\": [\"11237613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Butyrate activates two different protein kinase C isoforms that differentially phosphorylate Sp1 (dephosphorylation via serine/threonine phosphatases) and Sp3 (phosphorylation via ERK-MAPK); Sp1 dephosphorylation causes its displacement from the TLR5 promoter, while Sp3 phosphorylation promotes its binding and recruitment of p300 with histone acetylation and transcriptional activation.\",\n      \"method\": \"ChIP; EMSA; PKC isoform inhibitors; ERK-MAPK inhibition; phosphatase treatment; reporter assays; siRNA knockdown\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus pharmacological epistasis plus EMSA, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"27060138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"USP7, activated by ACE inhibitor treatment, translocates to the nucleus and binds Sp1/Sp3; HDAC1 deacetylates Sp1/Sp3. Endothelial Sp1 binds the Notch1 promoter and inhibits its transcription, with Sp3 enhancing this repression; endothelial-specific Sp1/Sp3 double-knockout reduces angiogenesis and activates the Notch1/VEGFR2 pathway.\",\n      \"method\": \"Endothelial-specific conditional knockout mice; chromatin immunoprecipitation; co-immunoprecipitation; retinal and tumor angiogenesis models\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific conditional KO with defined pathway epistasis, ChIP evidence for Notch1 promoter binding, co-IP for USP7-Sp1/Sp3 interaction, single lab\",\n      \"pmids\": [\"36759621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Ceramide reduces Sp3 acetylation and increases the Sp3/Sp1 ratio on the hTERT promoter, enhancing Sp3 repressor function. Ceramide reduces Sp1 binding and increases Sp3 binding to the hTERT promoter, resulting in reduced RNA polymerase II recruitment.\",\n      \"method\": \"Chromatin immunoprecipitation; EMSA; co-transfection reporter assays; siRNA knockdown of Sp1\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrates in vivo promoter occupancy changes plus acetylation assay, single lab\",\n      \"pmids\": [\"15951564\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Klf4 and Sp3 bind to the Notch1 promoter in keratinocytes and both function as overlapping transcriptional repressors; combined knockdown of Klf4 and Sp3 is required to increase Notch1 transcription, whereas knockdown of either alone is insufficient.\",\n      \"method\": \"ChIP; siRNA knockdown; reporter assays; overexpression studies\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus siRNA epistasis, single lab, two complementary methods\",\n      \"pmids\": [\"20442780\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Only Sp3 (not Sp1) is a constituent of the interferon-inducible iKIBP complexes at the PKR promoter; Sp3 binding at the KCS element in vivo is IFN-dependent, whereas Sp1 binding is not. Sp3 within the iKIBP complex recruits STAT1 and STAT2 to the KCS element in an IFN-dependent manner, implicating Sp3 specifically in inducible (not basal) PKR transcription.\",\n      \"method\": \"EMSA; oligonucleotide pull-down; chromatin immunoprecipitation; IFN treatment\",\n      \"journal\": \"Virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrates IFN-dependent in vivo binding of Sp3 specifically, pulldown for complex composition, single lab\",\n      \"pmids\": [\"12954221\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Sp1 and Sp3 binding sites largely overlap at chromatin in hematopoietic development; Sp3 cooperates with the Sp1 DNA-binding mutant (Sp1ΔDBD) to enable hematopoiesis but cannot substitute in the complete absence of Sp1. Stable chromatin binding of Sp1 is required to maintain robust differentiation trajectories, as loss of Sp1 DNA binding leads to distortion of cell fate decision timing.\",\n      \"method\": \"Embryonic stem cell differentiation; single-cell gene expression analysis; chromatin accessibility assays; Sp1 DNA-binding domain mutant cells\",\n      \"journal\": \"Epigenetics & chromatin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with defined mutants, single-cell analysis, chromatin profiling, single lab\",\n      \"pmids\": [\"31164147\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SP3 is a ubiquitously expressed zinc-finger transcription factor that can both activate and repress gene transcription depending on context: it represses Sp1-mediated activation by competing for shared GC-box binding sites and through a portable N-terminal repression domain that contacts the general transcription machinery; its transcriptional activity is regulated by post-translational modifications including acetylation by p300 (which converts it to an activator) and SUMOylation at K551 by the E3 ligase PIAS1 (which silences it by triggering heterochromatic gene silencing via recruitment of Mi-2, HP1, SETDB1, and SUV4-20H); it exists as multiple isoforms (115 kDa full-length plus internally initiated 80 kDa isoforms) with distinct functional properties; it associates with HDAC1/2 complexes (where CK2-phosphorylated HDAC2 is enriched), occupies distinct non-overlapping nuclear domains from Sp1, and is essential in vivo for tooth formation, bone ossification, normal hematopoiesis, cardiac development, and megakaryocyte proplatelet formation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SP3 is a ubiquitously expressed GC-box-binding zinc-finger transcription factor that acts as a bifunctional regulator, repressing or activating target genes depending on post-translational state and promoter context [#0, #6]. Its repressor function operates through at least two routes: direct competition with Sp1 for shared GC-box sites — including the formation of unusually stable multimeric SP3-DNA complexes at promoters with adjacent Sp sites that block Sp1 synergy [#0, #8] — and a portable N-terminal repression domain that acts independently of DNA binding by contacting the general transcription machinery [#1]. SP3 also produces internally initiated 80 kDa isoforms that retain GC-box binding but lack activation capacity and act as dominant inhibitors of Sp1/SP3-driven transcription [#2]. SP3 activity is set by competing modifications: acetylation by p300 at a single lysine converts SP3 into a strong activator, whereas SUMOylation at K551 — catalyzed by the E3 ligase PIAS1 acting with Ubc9 — silences SP3 and nucleates heterochromatin by recruiting Mi-2, HP1, SETDB1, and SUV4-20H with attendant H3K9/H4K20 trimethylation [#3, #6, #4, #10, #12]. SP3 partitions into distinct, non-overlapping nuclear domains from Sp1 and associates with HDAC1/2 corepressor complexes to enforce promoter hypoacetylation [#9, #5, #20]. In vivo knockout studies establish non-redundant developmental roles in tooth and enamel formation, skeletal ossification, cardiac morphogenesis, and erythroid/myeloid hematopoiesis, with combined Sp1/SP3 loss required for defects in megakaryocyte proplatelet formation and endothelial angiogenesis [#14, #15, #16, #17, #18, #26].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Established the founding mechanism of SP3 as a repressor — whether it antagonizes Sp1 by site competition rather than by a separate effector activity.\",\n      \"evidence\": \"Co-transfection in mammalian and Drosophila SL2 cells with DNA-binding-domain mutants and Sp1/SP3 chimeras\",\n      \"pmids\": [\"8070411\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify protein partners mediating repression beyond competition\", \"Did not address context-dependent activation\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Showed SP3 carries an autonomous repression activity, not merely passive site occupancy, by demonstrating a portable N-terminal domain that represses when tethered independently of the zinc fingers.\",\n      \"evidence\": \"DNA and RNA tethering of SP3 fusion proteins in co-transfection assays\",\n      \"pmids\": [\"8621476\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific general-transcription-machinery contacts not biochemically defined\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Resolved the molecular basis of SP3 functional heterogeneity by demonstrating internally initiated short isoforms that bind DNA but inhibit rather than activate.\",\n      \"evidence\": \"Internal translation initiation site mapping, in vitro DNA binding, and co-transfection\",\n      \"pmids\": [\"9224612\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological ratio control of isoforms not established\", \"Isoform-specific gene targets not defined\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Provided the first in vivo demonstration that SP3 is essential and non-redundant, defining roles in late tooth development and post-natal survival distinct from Sp1.\",\n      \"evidence\": \"Sp3-null mouse knockout with histology and target gene expression analysis\",\n      \"pmids\": [\"10675334\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct SP3 target genes in ameloblasts not mapped\", \"Degree of Sp1 redundancy quantified only qualitatively\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Extended SP3's developmental requirement to skeletal ossification and placed it downstream of or parallel to Cbfa1 in bone formation.\",\n      \"evidence\": \"Sp3-null embryo histology, osteocalcin expression, and in vitro ES cell osteogenic differentiation\",\n      \"pmids\": [\"11472836\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct osteoblast target promoters not identified\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identified acetylation as a switch and SUMOylation/PIAS1 as the silencing system, explaining how a single factor toggles between activator and repressor.\",\n      \"evidence\": \"In vivo/in vitro SUMO conjugation assays, PIAS1/Ubc9 co-IP, single-lysine mutagenesis, and in vitro transcription with depleted nuclear extract\",\n      \"pmids\": [\"12356736\", \"11812829\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crosstalk between acetylation and SUMOylation on the same residue context not fully resolved\", \"Stimulus that sets the modification balance not defined here\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Linked SP3 to HDAC corepressor machinery and showed CK2-phosphorylated HDAC2 is enriched in Sp1/SP3 complexes, connecting kinase signaling to SP3-associated deacetylase activity.\",\n      \"evidence\": \"Reciprocal co-IP, in situ cross-linking, CK2 kinase and phosphatase assays in breast cancer cells\",\n      \"pmids\": [\"12176973\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of HDAC2 phosphorylation on specific SP3 targets not shown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrated p300-mediated acetylation is required for SP3 to function as an activator, defining the molecular basis of its repressor/activator duality.\",\n      \"evidence\": \"p300 HAT assay, HAT-domain-deleted dominant-negative control, and reporter assays in Sp3-deficient cells\",\n      \"pmids\": [\"12837748\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Promoter features dictating activator versus repressor outcome not generalized\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Established cell-autonomous requirements for SP3 across hematopoietic lineages, separating its in vivo blood functions from those of Sp1.\",\n      \"evidence\": \"Sp3-null fetal liver transplantation and in vitro differentiation assays\",\n      \"pmids\": [\"12676787\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Lineage-specific direct targets not identified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Broadened the SP3 interactome to oncogenic and gene-specific contexts — c-Myc sequestration of Sp1/SP3 and IFN-dependent SP3-specific recruitment of STAT1/STAT2 at the PKR promoter.\",\n      \"evidence\": \"Co-IP and GST pulldown (c-Myc); EMSA, oligo pulldown, and ChIP under IFN treatment (PKR)\",\n      \"pmids\": [\"11274368\", \"12954221\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"c-Myc SP3 contact inferred from Sp1/SP3 complex, not direct\", \"Inducible versus basal partitioning mechanism at the KCS element unresolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Showed Sp1 and SP3 occupy spatially and physically distinct nuclear and chromatin compartments, and that SUMOylation of DNA-bound short isoforms (with Ubc9) drives TSA-insensitive repression.\",\n      \"evidence\": \"Deconvolution immunofluorescence, nuclear fractionation, re-ChIP; yeast two-hybrid and K551 mutagenesis\",\n      \"pmids\": [\"15987735\", \"15494207\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism keeping Sp1 and SP3 on separate promoter molecules unknown\", \"Determinants of compartment partitioning not defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined a direct developmental SP3 target by showing SP3 binds the Carp promoter and is required for cardiac looping and morphogenesis.\",\n      \"evidence\": \"Sp3-null mouse phenotyping, ChIP at the Carp promoter, and microarray\",\n      \"pmids\": [\"17923686\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SP3 acts as activator or repressor at Carp in vivo not fully resolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Provided the chromatin mechanism of SUMO-dependent silencing by showing DNA-bound SUMOylated SP3 nucleates heterochromatin through Mi-2, HP1, SETDB1, and SUV4-20H with H3K9/H4K20 trimethylation.\",\n      \"evidence\": \"ChIP for chromatin factors and histone marks on SUMO-modified SP3\",\n      \"pmids\": [\"18617891\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Order and dependency of factor recruitment not dissected\", \"Reversibility kinetics not characterized\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Revealed functional redundancy with Sp1 in megakaryocytes, where only combined loss disrupts the demarcation membrane system and proplatelet formation via downregulated cytoskeletal genes and MYLK.\",\n      \"evidence\": \"Conditional Sp1/Sp3 double-knockout mice (two Cre models), EM, transcriptomics, and platelet proteomics\",\n      \"pmids\": [\"25538045\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct SP3 binding at cytoskeletal/MYLK loci not shown\", \"SP3-specific contribution versus Sp1 not separated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Connected SP3 to endothelial angiogenesis control, showing SP3 enhances Sp1-mediated Notch1 promoter repression and that USP7 and HDAC1 regulate Sp1/SP3 in this axis.\",\n      \"evidence\": \"Endothelial-specific Sp1/Sp3 double-knockout mice, ChIP at Notch1, co-IP for USP7 binding, retinal and tumor angiogenesis models\",\n      \"pmids\": [\"36759621\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Independent SP3 promoter occupancy distinct from Sp1 not isolated\", \"Mechanism of USP7 selectivity for Sp1/SP3 unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the acetylation/SUMOylation/phosphorylation code, isoform ratios, and Sp1 redundancy are integrated to select activator versus repressor output at individual native promoters remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking modification state to genome-wide target outcome\", \"SP3-specific direct targets distinct from Sp1 largely undefined\", \"Structural basis of multimeric SP3-DNA complexes unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 2, 6]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 2, 8]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 2, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [9, 11]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [9, 12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 6]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [12, 5]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [14, 15, 17]}\n    ],\n    \"complexes\": [\n      \"HDAC1/2 corepressor complex\",\n      \"REST/HDAC1/HDAC2 repressor complex\"\n    ],\n    \"partners\": [\n      \"SP1\",\n      \"PIAS1\",\n      \"UBE2I\",\n      \"EP300\",\n      \"HDAC2\",\n      \"MYC\",\n      \"RELA\",\n      \"USP7\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}